This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Air Products and Chemicals (APD) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Air Products and Chemicals (APD) delivered earnings and revenue surprises of 4.33% and 8.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (ALB) Tops Q3 Earnings Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 9.65% and 1.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Energy Fuels (UUUU) This Earnings Season?
by Zacks Equity Research
Energy Fuels' (UUUU) third-quarter 2022 results might reflect the benefit of higher uranium prices as well as efforts to pursue new sources of revenues and lower costs.
Should Value Investors Buy Koppers (KOP) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Celanese (CE) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits from productivity actions, project investment, higher demand and strategic acquisitions are likely to get reflected in Celanese's (CE) third-quarter performance.
Barrick (GOLD) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Barrick's (GOLD) third-quarter results are expected to reflect lower realized gold prices and a decline in gold production.
Ternium (TX) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
The impacts of lower steel prices, softer demand and higher costs are likely to reflect Ternium's (TX) third-quarter results.
What's in Store for Piedmont Lithium (PLL) This Earnings Season?
by Zacks Equity Research
Piedmont Lithium's (PLL) third-quarter 2022 results are likely to reflect exploration and mine development costs as well as higher General and administrative expenses.
Analysts Estimate DuPont de Nemours (DD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Air Products (APD) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Air Products (APD) is expected to have gained from cost-improvement and productivity initiatives and higher pricing in the fiscal fourth quarter.
Will Higher Lithium Prices Drive Albemarle (ALB) in Q3 Earnings?
by Zacks Equity Research
Strong lithium prices and volumes are likely to have driven Albemarle's (ALB) performance in Q3.
Ryerson Holding (RYI) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Ryerson Holding's (RYI) third-quarter results are expected to reflect sequentially lower selling prices and volumes.
MP Materials (MP) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
MP Materials' (MP) third-quarter 2022 results are likely to benefit from higher volumes sold, increased realized pricing and gains stemming from efficiency improvements efforts.
Albemarle (ALB) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium volumes and prices and its cost-reduction actions in the third quarter.
CF Industries (CF) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
CF Industries' (CF) third-quarter performance is likely to reflect higher nitrogen prices and increased demand.
Nutrien (NTR) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Nutrien's (NTR) third-quarter performance will likely reflect the benefits of strong demand and higher prices for fertilizers.
Take the Zacks Approach to Beat the Market: Caterpillar, Amgen, Inventiva in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Koppers (KOP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Koppers (KOP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Livent (LTHM) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Livent's (LTHM) Q3 results are likely to reflect the benefits of higher realized pricing and strong lithium demand.
4 Chemical Stocks Poised to Outshine Q3 Earnings Estimates
by Anindya Barman
Healthy end-market demand and benefits of self-help actions are likely to have been reflected in the Q3 performance of Albemarle (ALB), Livent (LTHM), Koppers (KOP) and Huntsman (HUN).
Eastman Chemical (EMN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 2.50% and 5.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Linde (LIN) Q3 Earnings & Revenues Beat on Higher Prices
by Zacks Equity Research
Linde's (LIN) earnings in Q3 gain from higher prices and volumes across all end markets except for healthcare.
LyondellBasell (LYB) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
LyondellBasell's (LYB) Q3 results are likely to have been impacted by weaker demand and higher energy and raw material costs.
Newmont (NEM) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Improved production is likely to have aided Newmont (NEM) in Q3 amid lower gold prices.
FMC Corp (FMC) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
FMC Corp (FMC) is likely to have witnessed demand strength for its products and higher pricing in the third quarter.